Company Filing History:
Years Active: 2011-2013
Title: Kwei-Luen Hsu: Innovator in Radioactive Materials for Cancer Treatment
Introduction
Kwei-Luen Hsu is a prominent inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of nuclear medicine, particularly in the development of innovative radioactive materials aimed at cancer treatment. With a total of 2 patents, his work focuses on enhancing the efficacy of cancer therapies through advanced materials.
Latest Patents
Hsu's latest patents include groundbreaking inventions that utilize chitosan in radioactive materials. The first patent, titled "Radioactive material containing chitosan for inhibiting cancer and preparation method thereof," describes a method of creating a radioactive material that combines chitosan with radionuclides such as Re and Tc-99m. This innovative approach allows for the injection of the radioactive material into cancerous tissues, where it remains for an extended period, effectively targeting and treating cancer.
The second patent, "Radioactive mixture and manufacturing method thereof," details a radioactive mixture formed through a chelating reaction of MN series compounds with TcO or ReO, dissolved in Lipiodol. This mixture is designed to treat liver cancers and other solid tumors while minimizing the risk of injury to bone marrow. By leveraging the properties of Lipiodol, which remains in liver tumors for a prolonged duration, Hsu's invention offers a promising alternative to traditional surgical interventions.
Career Highlights
Kwei-Luen Hsu is affiliated with the Atomic Energy Council - Institute of Nuclear Energy Research, where he conducts research and development in nuclear medicine. His work has garnered attention for its potential to revolutionize cancer treatment methodologies. Hsu's innovative spirit and dedication to improving patient outcomes are evident in his research endeavors.
Collaborations
Hsu collaborates with I-Chung Tang, a fellow researcher, to further advance their work in the field of nuclear medicine. Their partnership exemplifies the importance of teamwork in driving innovation and achieving significant breakthroughs in cancer treatment.
Conclusion
Kwei-Luen Hsu's contributions to the field of nuclear medicine through his innovative patents highlight the potential of radioactive materials in cancer treatment. His work not only showcases his expertise as an inventor but also emphasizes the importance of research in developing effective therapies for challenging medical conditions.